Form 4: Aura Biosciences CEO Elisabet de los Pinos Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Elisabet de los Pinos, CEO of Aura Biosciences, sold 9,200 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On October 29, 2024, Elisabet de los Pinos, CEO of Aura Biosciences, sold 9,200 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $10.7378, with individual transactions ranging from $10.61 to $10.74.
- Following the transaction, de los Pinos directly owns 320,647 shares and indirectly owns 131,412 shares through the Elisabet de los Pinos Revocable Trust.
- The sales were automatic and not at the discretion of the reporting person.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, with no indication of a change in the executive's overall confidence in the company.
Industry Context
Executive share sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook on the company's future, especially when it's explicitly stated to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| April 8, 2016 | Date of the Elisabet de los Pinos Revocable Trust U/D/T |
| 10/29/2024 | Date of the share sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.